Frequently asked questions

Thalivia Community is an online space where intrathecal analgesia teams from different countries ask questions and discuss their cases with peers and lead experts. Questions are organised by category. An expert can open a private thread when a case calls for it. Exchanges are moderated by the Thalivia team and by lead experts.

Thalivia Community is reserved for healthcare professionals who practise intrathecal analgesia or wish to develop it. Access is by invitation. To request one, use the contact form and give your name, specialty, institution and country.

Thalivia Community is free for practitioners.

Yes. Thalivia Community is open to healthcare professionals whatever their country. Practices, rules and the organisation of care differ from one country to another: members can show their country in their profile, so that exchanges take into account the context of each person, and the community is a place to discuss these differences between peers.

The interface of Thalivia Community is available in English, French, Spanish and Italian.

Lead experts are experienced practitioners who answer the questions of their peers as their availability allows, can open private threads when a case calls for it and retain the answer that settles a question. If they wish, they also take part in moderation. See Become a lead expert.

Use the contact form and choose the subject Become a lead expert. Members and experts take part under their real name, as healthcare professionals.

No identifying patient data may be shared. Each practitioner is responsible for removing or altering any identifying element (name, date of birth, record number or any other information that could identify a patient) before publishing a case, and for describing it in general terms. Thalivia Community is a discussion space and does not host patient records. The platform is hosted in France by a certified health data host (HDS).

No. Exchanges between peers are a complement to clinical judgement, never a substitute. The practitioner in charge remains solely responsible for decisions concerning their patients.

Thalivia Traceability is software in development. CE marking and availability are planned for the first quarter of 2027. It is not available for clinical use until then. See the Thalivia Traceability page. Members of Thalivia Community are kept informed of its progress.

Both are in preparation. No training module is open yet, and the registry project is being prepared under independent scientific governance. Members of Thalivia Community are kept informed.

Thalivia is a brand of Thalensis SAS, founded by Charles Dupoiron. Dr Denis Dupoiron is the scientific advisor. See the About page.

Use the contact form and select the partnership or funding subject.